Focus on research: JAK2 mutations in ploycythemia vera - Molecular mechanisms and clinical applications

被引:32
作者
Tefferi, Ayalew [1 ]
机构
[1] Mayo Clin Coll Med, Dept Internal Med, Div Hematol, Rochester, MN 55905 USA
关键词
D O I
10.1056/NEJMp068293
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:444 / 445
页数:2
相关论文
共 5 条
[1]   A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].
James, C ;
Ugo, V ;
Le Couédic, JP ;
Staerk, J ;
Delhommeau, F ;
Lacout, C ;
Garçon, L ;
Raslova, H ;
Berger, R ;
Bennaceur-Griscelli, A ;
Villeval, JL ;
Constantinescu, SN ;
Casadevall, N ;
Vainchenker, W .
NATURE, 2005, 434 (7037) :1144-1148
[2]   Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders [J].
Jones, AV ;
Kreil, S ;
Zoi, K ;
Waghorn, K ;
Curtis, C ;
Zhang, LY ;
Score, J ;
Seear, R ;
Chase, AJ ;
Grand, FH ;
White, H ;
Zoi, C ;
Loukopoulos, D ;
Terpos, E ;
Vervessou, EC ;
Schultheis, B ;
Emig, M ;
Ernst, T ;
Lengfelder, E ;
Hehlmann, R ;
Hochhaus, A ;
Oscier, D ;
Silver, RT ;
Reiter, A ;
Cross, NCP .
BLOOD, 2005, 106 (06) :2162-2168
[3]   A gain-of-function mutation of JAK2 in myeloproliferative disorders [J].
Kralovics, R ;
Passamonti, F ;
Buser, AS ;
Teo, S ;
Tiedt, R ;
Passweg, JR ;
Tichelli, A ;
Cazzola, M ;
Skoda, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) :1779-1790
[4]   MPLW515L is anovel somatic activating mutation in myelofibrosis with myeloid metaplasia [J].
Pikman, Yana ;
Lee, Benjamin H. ;
Mercher, Thomas ;
McDowell, Elizabeth ;
Ebert, Benjamin L. ;
Gozo, Maricel ;
Cuker, Adam ;
Wernig, Gerlinde ;
Moore, Sandra ;
Galinsky, Ilene ;
DeAngelo, Daniel J. ;
Clark, Jennifer J. ;
Lee, Stephanie J. ;
Golub, Todd R. ;
Wadleigh, Martha ;
Gilliland, D. Gary ;
Levine, Ross L. .
PLOS MEDICINE, 2006, 3 (07) :1140-1151
[5]  
Tefferi A, 2005, CELL CYCLE, V4, P1053